CPA Journal Thanks Reviewers for Essential Support in 2025
Published 13 March, 2026
Current Pharmaceutical Analysis (CPA) extends sincere thanks to the expert scholars who dedicated their time and expertise as peer reviewers during 2025. The journal's commitment to publishing high-quality pharmaceutical analysis research is made possible through the diligent evaluations of its reviewers.
CPA also reports its current performance metrics, which include a real-time Impact Factor of 3.0 and a real-time CiteScore of 2.4. These indicators reflect the steady academic influence of the research published in the journal.
The editorial board acknowledges the vital role of peer reviewers in maintaining the integrity and advancement of pharmaceutical analysis as a discipline.
